Home›Companies›Healthcare›Escalante Bioscience

Escalante Bioscience, Inc.

Updated Oct 27, 2026·Latest SEC filing May 17, 2024·Suggest an edit

About Escalante Bioscience

Escalante Bioscience is a private company based in San Francisco, California, incorporated in 2024 in Delaware. It has reported $6,749,986 raised in one offering on Form D since May 2024. Its chief executive is Ching-Yun Hsu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 7, 2024May 17, 2024$6,749,986fully sold17$397KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Escalante Bioscience's Form D filed May 17, 2024.

AT
Akshay Tambe
Director
AS
April Schleck
Executive officer and director
CH
Ching-Yun Hsu
Chief Executive Officer and director
NB

Sources

  1. SECEscalante Bioscience, Inc. filing history